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La Réunion, an island in the Indian Ocean 
with a population of 785,000, experienced 
an outbreak of chikungunya fever, an arboviral 
disease transmitted by mosquitoes. In 2005–
2006, there were an estimated 300,000 cumu-
lated cases (Simon et al., 2006; Schuffenecker 
et al., 2006; Gérardin et al., 2008). The epi-
demic involved India, where estimates ap-
proach six million infected people, it emerged 
in Italy (Mavalankar et al., 2007; Watson, 
2007), and ongoing infections exist in South-
east Asia (Ng et al., 2009). The disease was first 
recognized during an epidemic in East Africa in 
1952–1953. The etiologic agent chikungunya 
virus (CHIKV) is a member of the Togaviridae 
family, genus Alphavirus (Johnston and Peters, 
1996), which are enveloped, single-stranded 
positive polarity RNA viruses. In humans, 
CHIKV typically induces symptoms 2–7 d after 
infection that are characterized by a rapid onset 
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Chikungunya virus (CHIKV) is the causative agent of an outbreak that began in La Réunion in 
2005 and remains a major public health concern in India, Southeast Asia, and southern Europe. 
CHIKV is transmitted to humans by mosquitoes and the associated disease is characterized by 
fever, myalgia, arthralgia, and rash. As viral load in infected patients declines before the 
appearance of neutralizing antibodies, we studied the role of type I interferon (IFN) in CHIKV 
pathogenesis. Based on human studies and mouse experimentation, we show that CHIKV does 
not directly stimulate type I IFN production in immune cells. Instead, infected nonhematopoi-
etic cells sense viral RNA in a Cardif-dependent manner and participate in the control of 
infection through their production of type I IFNs. Although the Cardif signaling pathway 
contributes to the immune response, we also find evidence for a MyD88-dependent sensor that 
is critical for preventing viral dissemination. Moreover, we demonstrate that IFN-/ receptor 
(IFNAR) expression is required in the periphery but not on immune cells, as IFNAR/→WT 
bone marrow chimeras are capable of clearing the infection, whereas WT→IFNAR/ chimeras 
succumb. This study defines an essential role for type I IFN, produced via cooperation between 
multiple host sensors and acting directly on nonhematopoietic cells, in the control of CHIKV.
© 2010 Schilte et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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and MAVS; Kawai and Akira, 2006). As CHIKV is an ssRNA 
virus and likely replicates with a dsRNA intermediary, we 
predicted engagement of TLR7 and/or TLR3. To our sur-
prise, our results indicate that CHIKV does not directly acti-
vate hematopoietic cells expressing these receptors. Instead, 
direct infection and engagement of a Cardif-dependant path-
way seems critical for initiating the host response to CHIKV. 
In addition, we find evidence for a second sensor pathway 
mediated by MyD88 that plays an important role in control-
ling viral dissemination.
Regarding the role of type I IFNs in disease pathogenesis 
and control of viral infection, there have been several viruses 
for which IFNAR expression has been shown to be essen-
tial. These include DNA (e.g., HV68 and MCMV), dsRNA 
(e.g., reovirus), positive ssRNA (e.g., Semliki Forest virus 
[SFV]), and negative ssRNA (e.g., VSV) viruses (Müller et al., 
1994; Aricò et al., 2004; Johansson et al., 2007). With that 
said, many viruses are also known to be controlled, even in 
the absence of IFNAR signaling, including VV and LCMV 
(Müller et al., 1994). Nonetheless, in situations in which infec-
tion is not lethal, type I IFNs play a role in coordinating an 
antiviral immune response and IFNAR/ mice have more 
severe infection with greater histopathology (Müller et al., 
1994; Havenar-Daughton et al., 2006). Although there are 
many gaps in our knowledge, it is important to note that in 
some cases, type I IFNs are acting primarily via IFN-stimulated 
genes (ISGs) with direct antiviral activity, whereas for other 
infections their dominant role is to stimulate humoral and 
cellular immunity. Our studies demonstrate that CHIKV is 
critically dependent on type I IFN action on nonhemato-
poietic cells and, thus, acts as a direct antiviral, likely through 
the induction of one or more ISGs. This study provides the 
first detailed information concerning the role of IFN-/ in 
reemergent CHIKV pathogenesis.
RESULTS
CHIKV infection results in high levels of type I IFNs but fails 
to directly trigger its production in hematopoietic cells
To establish a role for the induction of type I IFNs by 
CHIKV infection, we analyzed serum from a patient cohort 
recruited during the 2005–2006 outbreak in La Réunion. 
Indeed, IFN- was detected at high levels in the serum of 
infected individuals with its concentration correlating with 
viral load (Fig. 1 A). It is of note that plasma concentrations of 
IFN- in infected individuals were not statistically different 
from controls (unpublished data). We thus investigated the 
mechanisms, accounting for the production of type I IFNs 
during infection. Primary isolates of CHIKV were obtained 
and their genome sequence was determined (Schuffenecker 
et al., 2006). A representative isolate, CHIKV-21, is presented 
in this study. To avoid laboratory adaptation, viruses were 
amplified only twice in C6/36 mosquito cells and titrated by 
plaque assay on BHK cells.
Human plasmacytoid DCs (pDCs) are a robust source of 
type I IFNs (Siegal et al., 1999). Additionally, it has been 
shown that conventional DCs (cDCs) may express high levels 
of fever (peaking at 39–40°C) and severe arthralgia and my-
algia, which is followed by constitutional symptoms (head-
ache, photophobia, nausea, and abdominal pain) and a rash 
(Bodenmann and Genton, 2006; Borgherini et al., 2007). It 
has been reported that viremia peaks at day 2 after the initia-
tion of symptoms, declines sharply during days 3 and 4, and 
is undetectable by day 5 (Carey et al., 1969). Based on the 
sharp decline in viremia before the evolution of high-affinity 
neutralizing antibodies (Carey et al., 1969), we hypothesized 
that type I IFNs mediate this rapid antiviral response.
IFN was discovered by Alick Isaacs and Jean Lindemann 
in 1957 as an undefined substance with antiviral activity. 
Work within the last decades has defined this antiviral sub-
stance as type I IFN (IFN-/), distinguishing it from type 
II IFN (IFN-) and the more recently described type III IFN 
(IFN-; Sheppard et al., 2003). Leukocytes are the primary 
producers of IFN- and fibroblasts are the primary producers 
of IFN-. Various IFN- subtypes exist (at least 13; van Pesch 
et al., 2004) but only one IFN- subtype exists; however, all 
use a single IFN-/ receptor (IFNAR) and the functional 
significance of these multiple subtypes is not well understood. 
Interestingly, in the 1960s and 1970s, CHIKV was used to 
stimulate IFN production from chick embryo fibroblast-like 
cells (Friedman, 1964; Wagner, 1964). These were some of 
the last notable scientific articles that evaluated CHIKV in the 
context of the IFN pathway before the current epidemic.
The host immune response, and in particular the pro-
duction of IFN, is triggered by the engagement of recep-
tors that are termed pattern-recognition receptors (PRRs). 
Toll-like receptors (TLRs) and RNA helicases (referred to as 
RIG-I–like receptors [RLRs]) represent two classes of PRRs 
in mammals. Both types of PRRs have an essential role in 
the initiation of innate immunity by sensing invading patho-
gens through the recognition of conserved molecular motifs, 
termed pathogen-associated molecular patterns (PAMPs), 
which include structures such as surface glycoproteins, 
single-stranded RNA (ssRNA) or double-stranded RNA 
(dsRNA), and unmethylated CpG DNA. TLRs constitute 
a family of 11 members of transmembrane proteins, six of 
which have been implicated thus far in antiviral immunity 
(TLR-2, -3, -4, -7, -8, and -9). Viral surface glycoproteins 
(e.g., the hemagglutinin protein of measles virus) have been 
reported as agonists for TLR2 and TLR4 (Kurt-Jones et al., 
2000; Bieback et al., 2002; Rassa et al., 2002; Compton et al., 
2003). ssRNA viruses (e.g., influenza) trigger TLR7 and 
TLR8 signaling (Diebold et al., 2004), whereas extracellular 
dsRNA is recognized by TLR3 (Alexopoulou et al., 2001), 
and unmethylated CpG-containing DNA viruses (e.g., her-
pes simplex virus) may activate TLR9 (Krug et al., 2004). 
In this paper, we will refer to these receptors as extracellular 
sensors, as the agonist binding domains are topologically ori-
ented toward the extracellular space or lumen of the endo-
some. The family of intracellular sensors includes the RNA 
helicases Mda5 (melanoma differentiation–associated gene 5) 
and RIG-I (retinoic acid–inducible gene I), with both of 
them signaling through Cardif (also known as IPS-1, Visa, 
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a known agonist of TLR7 in pDCs, or poly I:C, a known 
agonist of TLR3 in cDCs, was added to the cell cultures. 
Together, these results suggest that although IFNs are pro-
duced during CHIKV disease pathogenesis, hematopoietic 
cells are not directly stimulated by CHIKV to produce IFN-
/. Although these observations could be explained as being 
a result of the failure of these cells to get productively infected 
(Sourisseau et al., 2007), it should be noted that pDCs are 
capable of producing IFNs in the absence of direct infection 
(Dalod et al., 2003).
Considering the requirement for direct infection, we next 
evaluated human fibroblasts, which are known targets of CHIKV 
infection (Sourisseau et al., 2007; Couderc et al., 2008), 
of IFN-/ (Diebold et al., 2003). To test CHIKV ability to 
directly trigger type I IFNs production in these cell types, we 
generated immature and mature monocyte-derived human 
cDCs, and we isolated pDCs from PBMCs based on their 
expression of BDCA-4. In addition, we tested unfraction-
ated PBMCs to evaluate other cell populations (e.g., mono-
cytes). Cells were exposed to 106 PFU CHIKV (range 10–50 
multiplicity of infection [MOI]) for 24 or 40 h, and culture 
supernatants were evaluated for the presence of type I IFNs. 
To our surprise, we could not detect IFN- (9/15 subtypes 
tested) or IFN- (unpublished data). These data were con-
firmed functionally using a reporter assay sensitive to IFNAR 
signaling (Fig. 1 B). As a positive control, influenza A/PR8, 
Figure 1. CHIKV induces IFN-/ in vivo in humans but fails to stimulate production in hematopoietic cells. (A) Patient sera samples were 
obtained from consenting CHIKV-infected adults (age = 16–86 yr; n = 25) and age-matched controls (age range = 16–89 yr; n = 17). IFN- was moni-
tored by luminex and plotted as a function of viral load, measured by quantitative PCR. Mean IFN- serum concentration in the control population was 
179 pg/ml, indicated by the dotted line. The solid line represents the linear regression between viral load and IFN- in patients. (B) Monocyte-derived DCs 
were generated from healthy donors, and 105 immature DCs (iDCs) or mature DCs (mDCs) were exposed to CHIKV. In parallel, 3 × 104 freshly isolated 
pDCs or 106 PBMCs were cultured with CHIKV. In the experiment shown, 106 PFU/ml was used and cells were incubated for 40 h. Culture supernatants 
were analyzed for IFN-/ production by a reporter assay involving an IFNAR-expressing cell line, HL-116, stably transfected with a plasmid encoding an 
IFN-inducible luciferase gene (limit of detection, 5 IFN U/ml). 50 HAU influenza A/PR8 or 50 µg/ml poly I:C were used as a positive control. Results were 
identical for three different donors. Similar results were found in monocyte-derived macrophages (not depicted). (C and D) Human foreskin fibroblasts 
(black) or MRC-5 cell lines (white) were infected at increasing MOI and cultured for 48 h. Cells were harvested and intracellular staining was performed 
using an anti-CHIKV mAb and analyzed by FACS (C). In parallel, culture supernatant was analyzed for IFN- by Elisa (limit of detection, 20 pg/ml; D). Error 
bars indicate SD. Data is representative of five experiments.
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in IFNAR/ mice infected with 106 PFU at 2 d after infec-
tion was >108 tissue culture infectious dose 50 (TCID50)/ml 
(not depicted). In contrast, WT animals cleared the infection 
with undetectable serum viral titers at all time points tested. 
These data are similar to those reported for IFNAR/ mice 
on the 129 strain (Couderc et al., 2008).
Next, we used STAT1/, STAT4/, and STAT6/ 
mice, establishing that STAT1 is critical for the clearance 
of CHIKV (Fig. 2 B). These data suggest that the canonical 
STAT1/2 heterodimer is responsible for transducing the signal 
from the IFNAR to control CHIKV infection. In contrast to 
the critical role for type I IFNs, mice deficient for IFN- do 
not develop viremia at day 2 and successfully cleared CHIKV 
infection (unpublished data). Although these data suggest a 
critical role for type I IFNs, no IFN-/ protein could be 
detected in the serum of WT animals across a time course of 3, 
6, 9, 24, 48, 72, and 96 h after infection. In stark contrast, we 
observed high levels of IFN- as well as IFN- in both the 
IFNAR/ and STAT1/ animals (Fig. 2, C and D; and not 
depicted). These results are likely a reflection of the high viral 
load in animals that are unable to signal via the IFNAR, as 
opposed to the rapid clearance of CHIKV in WT animals.
for their ability to produce IFN-/. Primary human foreskin 
fibroblasts and MRC-5 were both susceptible to infection at 
low MOI (Fig. 1 C), which correlated with the induction of 
high levels of IFN- (Fig. 1 D). Similar results were obtained 
for mouse hematopoietic cells, which could not be directly 
infected and did not produce type I IFNs, whereas mouse 
embryonic fibroblasts (MEFs) were sensitive to infection and 
produced robust amounts of IFN- (not depicted).
Type I IFNs acting via a STAT1 signaling pathway are critical 
for controlling CHIKV
To better define the role of IFN in the control of CHIKV 
and to identify the viral sensor responsible for its production, 
we developed a mouse model for CHIKV infection. Using 
IFNAR/ mice on the C57BL/6 strain, it was possible to 
demonstrate a critical role for IFNAR signaling in the control 
of CHIKV. Remarkably, 102 PFU injected intradermally (ID) 
was sufficient to kill the IFNAR/ mice between days 2.5 
and 4 after infection (Fig. 2 A). Injection of 106 PFU resulted 
in even faster death with all animals succumbing to infection 
between days 2 and 3. Similar to what was observed in highly 
viremic humans (Fig. 1 A; Laurent et al., 2007), the viral load 
Figure 2. CHIKV-infected IFNAR/ mice produce high levels of type I IFNs. (A) C57BL/6 IFNAR/ mice were infected ID with 102 PFU or 106 
PFU CHIKV. Survival was assessed twice a day and Kaplan-Meier survival curves were drawn (n = 5). (B) STAT1/, STAT4/, and STAT6/ (n = 5) mice, 
along with corresponding WT mice of a similar strain background, were infected ID with 106 PFU CHIKV. Survival was assessed twice a day and Kaplan-
Meier survival curves were drawn. (C and D) WT and IFNAR/ mice were infected with 106 PFU CHIKV and serum concentrations of IFN- and IFN- 
were monitored at day 2 after infection. Each dot represents an individual mouse, horizontal bars represent the mean. Data shown is combined from 
two independent experiments.
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ID into the ear and, 24 h later, the injection site was dis-
sected and analyzed by immunohistofluorescence. We 
observed GFP-positive cells in the injected skin lining se-
baceous glands, vessels, and the cartilage (Fig. 3 A). As GFP 
is not incorporated into the virion in the construct we used 
Local production of type I IFNs prevents viral dissemination 
in WT mice
To gain additional insight into how WT mice control 
CHIKV dissemination, we investigated the site of injec-
tion. Recombinant CHIKV expressing GFP was injected 
Figure 3. Local production of type I IFNs control viral dissemination in WT animals. (A) WT mice were injected with GFP-expressing CHIKV.  
Immunofluorescence was performed at day 1 after infection on skin at the site of injection (ear). Nuclei were stained with DAPI (blue) and replicating 
virus was detected using anti-GFP mAbs (green). Bar, 50 µm. (B) mRNA was isolated from the infection site at 3, 8, 24, and 48 h after infection. RT was per-
formed and IFN-, IFN-2, IFN-4, and Mx-1 mRNA expression was determined by quantitative PCR. Individual mice are represented by dots and horizon-
tal bars represent the mean. The experiment presented is representative of three independent experiments. (C) As in B, total RNA was isolated from 
infected skin at various times and viral load was assessed. Data from three independent experiments are plotted to indicate viral RNA over time. Indi-
vidual mice are represented.
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performed double labeling with CD45 and CHIKV-GFP. 
Screening >25 sections from multiple experiments, we did 
not observe any GFP-positive CD45-expressing cells. A rep-
resentative image is presented here (Fig. 4 A). To further 
characterize the nonhematopoietic cells, we labeled sections 
with anti-vimentin antibodies, which is a marker for fibro-
blasts and mesenchymal cells, anti-CD31 antibodies, which is 
a marker for endothelial cells, and anti–smooth muscle actin 
(SMA), which is a marker for vascular smooth muscle cell, 
pericytes, and myofibroblasts. We identified vimentin-posi-
tive CHIKV-infected cells (Fig. 4 B) and, in some instances, 
colocalization in SMAint cells, which is suggestive of myofi-
broblasts (Fig. 4 C, arrow). In most cases, GFP-positive cells 
were CD31 and SMA (Fig. 4, B and C). These data sug-
gest that like the IFNAR/ animals (Couderc et al., 2008), 
the dominant cell type infected by CHIKV in the skin of 
WT animals is fibroblasts. These data are compelling, as they 
constitute the first evidence of a primary viral isolate in-
fecting WT mice using the natural route of infection and 
(Vanlandingham et al., 2005), GFP detection provides direct 
evidence of viral replication.
To determine if the local infection triggered a local immune 
response, we performed quantitative RT-PCR analysis of the 
messenger RNA (mRNA) extracted from the injections site. 
Indeed, we observed a burst of IFN- and IFN-4 produc-
tion that peaked at 24 h after infection (Fig. 3 B). In addition, 
we observed the induction of IFN-2 and the IFN response 
gene Mx1, suggesting that the IFN priming loop is intact in 
CHIKV-infected WT mice (Fig. 3, D and E). Interestingly, 
the peak of IFN correlated with the decline in CHIKV load 
(Fig. 3 C). Collectively with the observation that WT mice 
do not have disseminated infection, we conclude that local 
IFN is capable of controlling CHIKV.
Fibroblasts are the dominant cell type infected with control 
of CHIKV mediated by a Cardif-dependant pathway
To more precisely define the cell type infected in the WT 
mice, we first evaluated infection of hematopoietic cells. We 
Figure 4. Skin fibroblasts, but not hematopoietic cells, are infected in WT mice. Immunofluorescence was performed 1 d after ID infection with 
CHIKV-GFP (A, C, and D) or with WT CHIKV (B) at the site of inoculation into the ear. Cell nuclei were stained with DAPI and replicating virus was detected 
using anti-GFP mAbs (A, C, and D) or with anti CHIK antibody (B). CD45 (A), Vimentin (B), or CD31 and SMA (C and D) staining was performed to deter-
mine the phenotype of infected cells. S, sebaceous gland; C, cartilage; arrow, infected myofibroblast (SMA+int). Bars, 20 µm. Data are representative of two 
independent experiments.
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again assessed survival and viral dissemination. Supporting the 
findings in the RIG-I/ and Mda5/, none of the Cardif/ 
mice infected with 106 PFU of CHIKV died from the infec-
tion (n = 15). There was, however, a reproducible pheno-
type. Viral titers in the Cardif/ were increased as compared 
with WT mice at 48 h after infection in the serum (Fig. 7 A), 
and low but detectable levels of virus were found in the skin, 
joints, liver, muscle, spleen, and serum at 72 h after infec-
tion (Fig. 7 B).
One possibility is that CHIKV is controlled through the 
sequential actions of two or more sensor pathways. Indeed, 
there is evidence in SFV that infected cells can trigger TLR-
dependant IFN production in phagocytic cells (Schulz et al., 
2005). Therefore, we evaluated MyD88/ and TLR3/. 
These mice also did not die from CHIKV infection (n = 10), but 
significant viral dissemination could be observed in MyD88/ 
animals, especially at later time points (Fig. 7 B). Notably, none 
of the sensor-deficient mice tested were as susceptible to infec-
tion as IFNAR/ animals, indicating that host sensor pathways 
cooperate for the control of CHIKV infection.
Type I IFNs act on nonhematopoietic cells for the control  
of CHIKV infection
Finally, we asked if the type I IFNs induced by viral infec-
tion acts directly on infected cells to mediate viral control or 
if immune cells are the requisite target of the type I IFNs, 
thus facilitating indirect control of CHIKV infection. To as-
sess these two possibilities, we established bone marrow chi-
meric mice by lethal irradiation of host CD45.1 WT mice, 
followed by adoptive transfer of CD45.2 IFNAR/ bone 
marrow (both mice were on a C57BL/6 background). Mice 
are referred to as IFNAR→WT. Strikingly, the IFNAR→
WT chimeras were capable of limiting infection, suggesting 
that host stromal cells alone, receiving IFNAR stimulation, 
are sufficient for controlling the virus (Fig. 8). Similar results 
were observed in IFNAR→Langerin-DTR mice treated 
with diptheria toxin to deplete the radio-resistant Langerhans 
cells in the skin (unpublished data). Supporting this conclu-
sion, we observe that in the WT→IFNAR chimeras, WT 
are consistent with the observations made in infected human 
tissue samples (Couderc et al., 2008).
We next considered the host sensor responsible for 
detecting infection and triggering IFN production. For 
ssRNA viruses such as CHIKV, which replicate via a puta-
tive dsRNA intermediary (Strauss and Strauss, 1994), triggers 
include TLR3, TLR7, PKR, Mda5, and RIG-I (Stetson and 
Medzhitov, 2006). To date, the host sensor for members of 
the family of Togaviridae remains unknown. We first considered 
intracellular sensors and tested infection in MEFs derived from 
Cardif/ animals. Cardif (also known as MAVS/VISA/IPS-1) 
is the critical adaptor downstream of RIG-I and Mda5.
Cardif/ MEFs were exposed to increasing MOI of virus 
and CHIKV antigen expression was monitored. Cardif/ 
MEFs were more sensitive to infection than their WT coun-
terparts, especially at a lower MOI (Fig. 5 A). We next eval-
uated IFN production and, strikingly, the Cardif/ MEFs 
failed to produce IFN- (Fig. 5 B) This was confirmed at the 
RNA level with the Cardif/ expressing 500-fold less IFN- 
mRNA as compared with the WT MEFs (Fig. 5 C). Based 
on these data, we suggest that infected fibroblasts respond to 
CHIKV infection via a Cardif-dependant sensor, producing 
type I IFNs and limiting infection.
Multiple viral sensors are involved in the in vivo control  
of CHIKV infection
To determine the upstream sensor responsible for engaging 
Cardif, we compared RIG-I– and Mda5-deficient MEFs 
(Fig. S1) and animals (Fig. 6). Viral titers were measured in 
the joint, muscle, liver, spleen, skin, and serum of infected 
animals. Although we observed a higher viral titer in the 
serum of RIG-I/ mice as compared with WT animals, the 
results were confounded by the increased sensitivity of out-
bred WT mice to CHIKV infection (Fig. 6). Notably, viral 
titers were evident in the joint of WT ICR mice. More strik-
ing was the fact that the RIG-I/ and Mda5/ mice had 
such a subtle phenotype.
To gain better insight into the in vivo response to CHIKV, 
we infected Cardif/ (C57BL/6 background) animals and 
Figure 5. Cell-intrinsic control of CHIKV in fibroblasts is mediated by intracellular sensors. (A) Cardif/ and the corresponding WT control MEFs 
were infected with increasing MOI of CHIKV. At 48 h, cells were analyzed by FACS for expression of CHIKV antigens. (B) Culture supernatants were har-
vested at 48 h and analyzed for IFN- protein. As a positive control, MEFs were exposed to FluNS1. (C) IFN- mRNA induction was measured by RT-PCR 
at 24 h after infection. The mean of three independent experiments is shown. Error bars show SD.
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the production and target of type I IFNs in CHIKV patho-
genesis. Specifically, we report that fibroblast production of 
type I IFNs is under the control of Cardif (Fig. 5). Further-
more, we demonstrate that IFN acts on nonhematopoietic 
cells to achieve viral clearance (Fig. 8).
Although these data suggest a central role for fibroblasts 
in the production and reception of IFN signals, the host 
response to CHIKV is more complex. Notably, adult Cardif/ 
mice infected with CHIKV had only a subtle phenotype. 
In addition to a role for the RLR pathway, we find that 
mice lacking MyD88 also became viremic (Fig. 7). Alone, 
neither of the pathways account for the phenotype observed 
in the IFNAR/ mice, suggesting that there is coopera-
tion between RLR and TLR recognition, acting together to 
mediate rapid clearance of CHIKV.
Based on the tissue tropism (Fig. 4), we argue that Car-
dif is engaged as a result of fibroblast and stromal cell infec-
tion. We attempted to define the upstream sensor, namely 
RIG-I or Mda5. As reported for the Cardif/, neither of the 
sensor-deficient animals had a strong phenotype, although 
both demonstrated increased viral load in selected tissues 
as compared with control animals (Fig. 6). One caveat is 
that the RIG-I and Mda5 knockouts are of a mixed ICR/
C57BL/6/129 background as a result of problems of lethality 
bone marrow was unable to rescue the IFNAR/ mice. 
These data indicate that IFNAR responsiveness is required in 
the radio-resistant stromal cells, distinguishing CHIKV from 
other viruses such as reovirus (Johansson et al., 2007), which 
also kills IFNAR/ but may be controlled by chimerism 
with WT BM-derived cells.
DISCUSSION
In this paper, we have characterized the mechanisms of viral 
control in CHIKV infection and we demonstrate a critical 
role for type I IFNs. We provide evidence in infected human 
subjects that CHIKV infection triggers the production of type I 
IFNs (Fig. 1 A). It has previously been reported that CHIKV 
does not directly infect primary leukocytes (Sourisseau et al., 
2007). Nonetheless, we expected that an ssRNA virus would 
be capable of directly activating hematopoietic cells. Remark-
ably, our in vitro stimulation of human PBMC, as well as 
human and mouse DC subsets, indicates that CHIKV is not 
capable of directly engaging PRRs for the induction of type I 
IFNs (Fig. 1 B and data not depicted). Instead, we suggest that 
infected fibroblasts are the source of type I IFN. This conclu-
sion is based on in vitro experiments and investigation of 
the injection site of WT animals (Fig. 1 D and Fig. 3). The use 
of defined knockout mice allowed us to further characterize 
Figure 6. Redundancy between RIG-I and Mda5 pathway. Mda5/, RIG-I/, and littermate WT controls were infected. Tissues and serum were 
collected 72 h after infection and viral titers were determined using TCID50. The limits of detection are indicated by dotted lines. Individual mice are repre-
sented and the geometric means are indicated by bars. A Mann-Whitney U test was used and, where significant, p-values are reported. Data shown is 
combined from two independent experiments.
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ways (Fig. S1). Based on these observations, we suggest that 
there is a shared role for both RIG-I and Mda5, as has been 
reported for West Nile virus (Fredericksen et al., 2008). In 
addition to these two sensors, it will also be important to 
explore a role for PKR and NOD2, both of which have now 
been implicated in the response to ssRNA viruses and may 
(Kato et al., 2006). In contrast to inbred animals used in our 
studies, the outbred WT controls showed CHIKV replica-
tion in the joint, making the data in the knockout strains 
harder to interpret. Additionally, MEFs isolated from these 
animals showed high variability, indicating that other genetic 
loci may be impinging on the Cardif-mediated sensor path-
Figure 7. Cross talk between Cardif- and MyD88-dependant pathways for efficient clearance of CHIKV. Cardif/, MyD88/, TLR3/, and the 
corresponding WT controls were infected with 106 PFU. (A) Viral titer was measured at 24 and 48 h after infection. As a control we show infection of an 
IFNAR/ animal. (B) Tissues were collected 72 h after infection and viral titers were determined using TCID50. The limits of detection are indicated by 
dashed lines. Individual mice are represented and geometric means are indicated by bars. It is of note that IFNAR mice are dead at that time point. Mann-
Whitney U test was used and, where significant, p-values are reported. Data shown is combined from two independent experiments.
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ing in the control of viruses. Specifically, IL-1R activation 
enhances survival in a model of influenza infection (Schmitz 
et al., 2005). Supporting this observation, mice deficient in 
Caspase-1, ASC, and NALP3 have been shown to have a 
defect in the control of influenza (Ichinohe et al., 2009). As 
such, IL-1 or IL18 produced by CHIKV-infected cells may 
participate in viral control by stimulating noninfected cells in 
a MyD88-dependant manner.
Regarding the role of type I IFNs, we provide evidence 
that IFNAR signaling in radioresistant stromal cells is criti-
cal for clearance of CHIKV. This was demonstrated using 
WT→IFNAR/ bone marrow chimeras, which died with 
a similar kinetic as the IFNAR/ animals (Fig. 8). Using the 
IFNAR/→WT chimeras, we also demonstrated that the 
IFN amplification loop in hematopoietic cells is not required 
for the control of CHIKV dissemination. To our knowledge, 
there is only one prior study that has taken a similar approach. 
In the case of reovirus infection, it is known that infection 
kills IFNAR/, and the gut epithelium, but not hematopoi-
etic, cells are the target of infection (Fleeton et al., 2004). Dis-
tinguishing our findings with CHIKV, it is interesting that 
Johansson et al. (2007) find that IFNAR/→WT succumb to 
signal via Cardif (Ryman and Klimstra, 2008; Barry et al., 
2009; Sabbah et al., 2009).
Regarding the role for MyD88, two possible pathways 
may account for its role in the control of CHIKV infection. 
As previously stated, hematopoietic cells are not directly stim-
ulated, suggesting that CHIKV does not engage TLRs in a 
conventional manner. There is, however, the possibility that 
endosomal TLRs are engaged as a result of hematopoietic 
cells phagocytosing infected cells, the latter being a source 
of viral PAMPs. For example, cells infected by SFV, also a 
member of the Alphavirus genus, results in the generation of 
dsRNA that may engage TLR3 on CD8+ DCs upon engulf-
ment (Schulz et al., 2005). Although TLR3 utilizes TRIF 
and thus does not help explain the phenotype in MyD88/ 
mice, this mechanism of PAMP transfer may generalize for 
other host sensors, and future studies will explore a role for 
TLR7 or TLR8. A second pathway for engaging MyD88 
concerns its role as an adaptor of the IL-1 and IL18 recep-
tors (Muzio et al., 1997). There has been a surge of new infor-
mation regarding the role of the inflammasome, which is well 
recognized as critical for IL-1 production after bacterial 
infection. Indeed, this pathway also seems to be participat-
Figure 8. IFNAR/→WT bone marrow chimeras maintain their ability to clear CHIKV infection. WT and IFNAR/ mice were lethally irradiated 
and reconstituted with bone marrow from IFNAR/ or WT mice, respectively. After 2–3 mo, chimeric mice were inoculated with 102 or 106 PFU CHIKV.  
(A) Survival was monitored twice a day for 2 wk and Kaplan-Meier curves are shown (n = 8 mice). Data represents two independent experiments. (B) At 
day 3 after infection, virus titer was determined using TCID50 in IFNAR→WT and WT controls (n = 3 mice). Dashed lines represent the limit of detection. 
Horizontal bars represent mean.
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2 µl of extracted RNA, 7.5 µl of LightCycler RNA Master Hyb-Probe, 3.25 
mmol/liter Mn2, 450 nmol/liter CHIKV forward primer (5-AAGCTCC-
GCGTCCTTTACCAAG-3), 150 nmol/liter CHIKV reverse primer (5-
CCAAATTGTCCGGGTCCTCCT-3), and 150 nmol/liter CHIKV probe 
(5, 6-carboxyfluorescein-3 TAMRA [5-CCATGTCTTCAGCCTGGAC-
ACCTTT-3]; TIB MOL-BIOL). The thermal cycling consisted of a reverse 
transcription at 61°C for 20 min followed by 45 cycles at 95°C for 5 s 
and 60°C for 15 s. The fluorescence was measured at 530 nm. CHIKV load is 
measured using a synthetic RNA calibrator (Laurent et al., 2007). For mouse 
IFN-, mouse IFN-2, mouse IFN-4, and Mx1, RT was performed with 
random primers (Roche) and complementary DNA (cDNA) was detected 
using Applied Biosystem Taqman probes (Mm00439546-s1, Mm00833961_s1, 
Mm00833969_s1, and Mm00487796-m1).
Mice. C57BL/6 mice were obtained from Charles River. Mice lacking the 
IFNAR1 were backcrossed >10× onto the C57BL/6 background (referred 
to as IFNAR/). Stat-4/ and Stat-6/ (BALB/c) were provided by A. 
Freitas (Institut Pasteur, Paris, France), and Stat-1/ (129) was purchased 
from Taconic. TLR3/ was provided by Pasteur animal facility, Cardif/ 
(B6) was generated by J. Tschopp, and MyD88/ (C57BL/6 background), 
RIG-I/, and Mda5/ mice (ICR/129/C57BL/6 mixed background) 
were generated and provided by S. Akira (Osaka University, Osaka, Japan; 
Kato et al., 2006). Langerin-DTR transgenic mice were provided by B. 
Malissen (Centre d’Immunologie Marseille-Luminy, Marseille, France; 
Kissenpfennig et al., 2005). For bone marrow chimera, hosts were irradiated 
with 1,050 Rad and 3 × 106 donor bone marrow cells were injected intrave-
nously. Bone marrow chimerism was assessed after 8 wk with 90–98% chime-
rism for all animals. Mice were inoculated ID with 50 µl of viral suspension 
diluted with PBS. The principles of good laboratory animal care were fol-
lowed all through the experimental process. Infections were performed in 
containment isolators under SPF conditions. All protocols were approved by 
the Institutional Committees on Animal Welfare of the Institut Pasteur.
Cells. Human blood components were obtained from the EFS (établisse-
ment français du sang). PBMCs were isolated using Ficol-Paque PLUS (GE 
Healthcare). pDCs were isolated from 250 × 106 PBMCs using the anti–
BDCA-4 magnetic beads (Miltenyi Biotec) according to the manufacturer’s 
protocol (90–95% purity was achieved). Immature DCs were prepared from 
the T cell–depleted fraction by culturing cells in the presence of 1,000 U/ml 
GM-CSF (Bayer HealthCare) and 500–1,000 U/ml IL-4 (R&D Systems) 
for 6 d (Bender et al., 1996; Romani et al., 1996). To generate mature DCs, 
cultures were stimulated on day 6 with 50 ng/ml TNF (Enzo Life Sciences, 
Inc.) and 0.1 µM PGE2 (Sigma-Aldrich) for 36–48 h (Rieser et al., 1997). 
At days 6–7, >95% of the cells were CD14CD83HLA-DRlo DCs. 
After maturation, on days 8–9, 70–95% of the cells were of the mature 
CD14CD83+HLA-DRhi phenotype. HFF and MRC5 were obtained from 
American Type Culture Collection. MEFs were generated from pregnant 
knockout mice 13 d after mating.
Antibodies, flow cytometry, and immunohistofluorescence. To de-
tect CHIKV viral proteins, we used a mouse mAb directed against a con-
served region of the Alphavirus nucleocapsid protein (Anti-C), a gift of I. 
Greiser-Wilke (Institute of Virology, Hanover, Germany; Greiser-Wilke et al., 
1989), and mouse polyclonal anti-CHIKV antibodies (Schuffenecker et al., 
2006). For detection of intracellular CHIKV proteins, cells were permeabi-
lized before labeling and analyzed by flow cytometry using a FACSCanto 
(BD) and FlowJo software (Tree Star, Inc.).
For immunohistofluorescence with CHIKV-GFP, tissues were fixed 
in 4% PFA for several hours, rinsed, and frozen in OCT. Slides were stained 
overnight at 4°C with primary antibody and 1 h with secondary antibody 
at room temperature, and then slides were counterstained with DAPI (In-
vivoGen). The following antibodies were used: rabbit anti-GFP (clone 
A11122; 1/1,000; Invitrogen), PE-conjugated mouse anti-CD45.2 (clone 
104; 1/200; BD), APC-conjugated rat anti–mouse CD31 (clone MEC13.3; 
1/150; BD), cy3-conjugated mouse monoclonal anti–-SMA (clone 1A4; 
infection, whereas WT→IFNAR/ chimeras control reovi-
rus. Although we fully acknowledge that IFN may be acting 
as both a direct antiviral and a proimmune cytokine in both 
cases, the former seems to be critical in CHIKV infection, 
whereas the latter is required for clearance of reovirus.
In addition to the importance of studying CHIKV patho-
genesis because of the threat to public health, from a funda-
mental level, we have identified features that make CHIKV 
unique as compared with other alphaviruses. Notably, Ross 
River, Sindbis, SFV, and Venezuelan Equine Encephalitis are 
known to infect and stimulate DCs (Hidmark et al., 2005; 
Ryman et al., 2005; Shabman et al., 2007). It should be noted 
that human and mouse DCs are not similar in their sensitiv-
ity to these viruses (Shabman et al., 2007); however, in the 
case of CHIKV, neither human nor mouse DCs are directly 
infected. Recent data would thus indicate that in this regard, 
CHIKV is more similar to Eastern Equine Encephalitis Virus 
(Gardner et al., 2008). Extending it to other arboviruses, we 
also note that infection in the WT mice failed to demonstrate 
evidence for direct infection of CD45+ cells, including Lang-
erhans cells, thus distinguishing CHIKV from other vector 
borne infections such as Dengue (Wu et al., 2000). This is 
relevant, as it indicates that the viral sensor as well as the 
host response in CHIKV pathogenesis may be distinct from 
other alphaviruses (MacDonald and Johnston, 2000; Ryman 
et al., 2005; Shabman et al., 2007). Also unique may be the 
ISG responsible for antiviral activity. For SFV, MxA confers 
resistance (Landis et al., 1998), whereas ISG15 appears critical 
for controlling Sindbis virus (Lenschow et al., 2007). Future 
work will be aimed at defining the ISG in fibroblasts that 
actively controls CHIKV replication.
In sum, we believe our study provides important insight 
into developing preventive measures and therapeutic strate-
gies for controlling CHIKV infection. Our results also sug-
gest a role for nonhematopoietic cells as important players for 
IFN production and viral control.
MATERIALS AND METHODS
Cytokine analysis. Sera were harvested and conserved at 80°C for anal-
ysis. IFN- was measured by Luminex (25-plex kits; Invitrogen) according 
to the manufacturer’s instructions. Human IFN- and mouse IFN-/ lev-
els were quantified by Elisa (PBL InterferonSource and Fujirebio Diagnos-
tics, Inc.). Human IFNAR activation was quantified using HL-116 lines 
(provided by G. Uzé, université Montpellier, Montpellier, France) express-
ing luciferase under an ISRE element. In brief, supernatant were treated for 
at least 48 h at pH 2.0 to destroy the virus, the pH was then equilibrated, and 
supernatants were added on the HL-116 cells. 6–8 h later, cells were lyzed 
and luciferase activity was read by luminometer. Intron A (Scherring Plough) 
was used to generate the standard curve.
Quantitative RT-PCR for quantification of viral load and IFN 
mRNA. For determination of patient viral load, total nucleic acid extrac-
tion was performed in a MagNa Pure automate using the Total Nucleic Acid 
kit (Roche). For analysis of cells, an RNeasy mini kit with DNase treatment 
(QIAGEN) was used. For tissues, samples were homogenized in Trizol, mixed 
with phenol-chloroform, and the aqueous phase was treated with the RNeasy 
mini kit . CHIKV RNA was detected with specific taqman probes using a one-
step RT-PCR (Master RNA hybridization probes; Roche) performed on a 
Chromo 4 machine (Bio-Rad Laboratories). The 20-µl reaction mix contained 
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1/600; Sigma-Aldrich). For staining of vimentin, tissues were not fixed 
and, instead, flash frozen in liquid nitrogen as previously described 
(Couderc et al., 2008). A chicken polyclonal anti-vimentin antibody was 
used (Abcam; 1/200). Images were acquired with an Axiovert 200 fit 
with an ApoTome and AxioVision 4.6 software (Carl Zeiss, Inc.).
CHIKV titer in mouse tissues and serum. Mice were perfused with 40 ml 
of saline buffer. Tissues were homogenized. Viral samples were titrated as 
TCID50 endpoint on Vero cells using a standard procedure. Serial 10-fold 
dilutions (100 µl) of tissue homogenate or serum were added in six replicates 
in 96-well plates seeded with 104 Vero cells. The cytopathic effect was 
scored 5 d after infection and the titer was calculated by determining the last 
dilution giving 50% of wells with cells displaying a cytopathic effect. Results 
were expressed as TCID50/ml in the serum and TCID50/g of tissue.
CHIKV infection. The preparation of CHIKV from clinic clinical samples 
has been previously described (Schuffenecker et al., 2006). CHIKV-21 strain 
was propagated in C6/36 cells, and supernatants were harvested and frozen 
at 80°C before titration and further use. Adherent cells (plated at 50% 
confluence in 24-wells plates) and nonadherent cells were exposed to the in-
dicated viruses for 2–4 h at 37°C, extensively washed (except for PBMC and 
for the RNA experiment on MEF), and cultivated for various periods of 
time before further analysis. The MOI was defined as the amount of CHIKV 
infectious units (calculated on BHK cells as PFU) per one target cell. 
3CHIKV-EGFP was generated using a full-length infectious cDNA clone 
provided by S. Higgs (Vanlandingham et al., 2005). Infectious virus was ob-
tained by transfection of BHK21 cells with RNA-derived cDNA, as de-
scribed. Viral titers in IFNAR/ mice at day 2 were equivalent to WT 
CHIKV (Fig. S2). As positive control, pIC (InvivoGen) with or without 
DOTAP (Roche) was used. Alternatively, cells were stimulated with influ-
enza virus strain A/PR8/1976 (Charles River) or with FluNS1 (given by 
S. Diebold; King’s College, London, UK) at 10 HAU/ml.
Online supplemental material. Fig. S1 shows that IFN- production 
in RIG-I/ and Mda5/ MEFs is strain dependant. Fig. S2 shows viral 
load in IFNAR/ mice infected with CHIKV-21 and CHIKV-GFP. Online 
supplemental material is available at http://www.jem.org/cgi/content/full/ 
jem.20090851/DC1.
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